Recently updated ACC/AHA guidelines redefine blood pressure (BP) categories as Stage 1 hypertension (systolic 130-139mmHg or diastolic 80-89mmHg), Elevated (systolic 120-129mmHg and diastolic <80mm) and Normal (<120/<80 mmHg), but their relevance to an obstetric population is uncertain. We sought to evaluate preeclampsia risk based on early pregnancy BP category and trajectory. STUDY DESIGN: This is a secondary analysis from a prospective observational study of nulliparous women with singleton pregnancies conducted at eight clinical sites between 2010-2014 (nuMoM2b cohort). Women included in this analysis had no history of prepregnancy hypertension (HTN) or diabetes. We compared the frequency of preeclampsia and gestational HTN among women based on BP category at first study visit (Normal, Elevated, or Stage 1 HTN) and systolic BP trajectory between two study visits. BP trajectories were categorized based on systolic BP difference between visit 1 and 2 as stable (<5mmHg difference), upward (!5mmHg) or downward ( -5mmHg) and by change in category between visits. Associations of BP category and trajectory with preeclampsia risk were assessed via univariate analysis and multinomial logistic regression analysis including co-variates identified in a backward stepwise approach. RESULTS: 8,924 women were included in the analysis. Study visit 1 occurred at mean gestational age (GA) 12.1 AE 1.5 weeks and study visit 2 at mean GA 19.0 AE 1.6 weeks. First trimester BP category was significantly associated with subsequent preeclampsia and gestational HTN, with increasing BP category associated with a higher risk. Stage 1 HTN at baseline was associated with an increased risk for all categories of pregnancy-associated HTN; increased in a stepwise fashion over Elevated BP at baseline (see table) . Systolic BP trajectory was significantly associated with preeclampsia risk (p<0.001) as was change in BP category between visits (p<0.001). Compared with a stable systolic trajectory, an upward trajectory was associated with an aOR 1.77 (95%CI 1.45-2.17) of preeclampsia after adjustment for maternal age, race, body mass index and first trimester BP (see figure) . CONCLUSION: In nulliparous women, BP category and systolic trajectory in early pregnancy are independently associated with preeclampsia risk. These findings may aid in identification of women who might benefit from risk-reducing interventions in the late first and early second trimester, such as low-dose aspirin.
OBJECTIVE:
Recently updated ACC/AHA guidelines redefine blood pressure (BP) categories as Stage 1 hypertension (systolic 130-139mmHg or diastolic 80-89mmHg), Elevated (systolic 120-129mmHg and diastolic <80mm) and Normal (<120/<80 mmHg), but their relevance to an obstetric population is uncertain. We sought to evaluate preeclampsia risk based on early pregnancy BP category and trajectory. STUDY DESIGN: This is a secondary analysis from a prospective observational study of nulliparous women with singleton pregnancies conducted at eight clinical sites between 2010 -2014 . Women included in this analysis had no history of prepregnancy hypertension (HTN) or diabetes. We compared the frequency of preeclampsia and gestational HTN among women based on BP category at first study visit (Normal, Elevated, or Stage 1 HTN) and systolic BP trajectory between two study visits. BP trajectories were categorized based on systolic BP difference between visit 1 and 2 as stable (<5mmHg difference), upward (!5mmHg) or downward ( -5mmHg) and by change in category between visits. Associations of BP category and trajectory with preeclampsia risk were assessed via univariate analysis and multinomial logistic regression analysis including co-variates identified in a backward stepwise approach. RESULTS: 8,924 women were included in the analysis. Study visit 1 occurred at mean gestational age (GA) 12.1 AE 1.5 weeks and study visit 2 at mean GA 19.0 AE 1.6 weeks. First trimester BP category was significantly associated with subsequent preeclampsia and gestational HTN, with increasing BP category associated with a higher risk. Stage 1 HTN at baseline was associated with an increased risk for all categories of pregnancy-associated HTN; increased in a stepwise fashion over Elevated BP at baseline (see table) . Systolic BP trajectory was significantly associated with preeclampsia risk (p<0.001) as was change in BP category between visits (p<0.001). Compared with a stable systolic trajectory, an upward trajectory was associated with an aOR 1.77 (95%CI 1.45-2.17) of preeclampsia after adjustment for maternal age, race, body mass index and first trimester BP (see figure) . CONCLUSION: In nulliparous women, BP category and systolic trajectory in early pregnancy are independently associated with preeclampsia risk. These findings may aid in identification of women who might benefit from risk-reducing interventions in the late first and early second trimester, such as low-dose aspirin.
Poster Session II OBJECTIVE: It has been suggested that early onset preeclampsia (EPE) and late onset preeclampsia (LPE) represent two different and distinct entities. LPE is more common, and usually less severe than EPE. Yet, while these terms are widely used, there is no clear definition of the gestational age cut-off between early and late preeclampsia, and various studies named different thresholds between 32 and 36 weeks. We aimed to establish this gestational age cut-off using placental pathology, mainly maternal vascular malperfusion lesions (MVM's), which are the hallmark of placental findings in preeclampsia. STUDY DESIGN: This was a retrospective analysis of all women with singleton gestations, at or beyond 24 weeks of gestation, diagnosed with preeclampsia, who delivered between 2001 and 2015 at a single, tertiary referral center. Placental abnormalities were classified into lesions related to maternal vascular malperfusion, fetal vascular malperfusion, lesions associated with hemorrhage and chronic inflammation. Placental findings were compared by gestational age at delivery. RESULTS: A total of 430 women with singleton gestation and preeclampsia were eligible for analysis. Out of all of the placental pathology parameters examined, MVM's emerged as potential candidate to define the gestational age cut-off between LPE and EPE, as the prevalence of these findings decreased significantly at 35 0/7 weeks of gestation (Figure) . The prevalence of one or more MVM's was significantly higher < 35 0/7 weeks of gestation (93.2% vs. 47.3%, p<0.001) (Table) . Comparing the prevalence of !2 and !3 different types of MVM's (as more sensitive markers of placental ischemia), before and after 35 0/7 weeks of gestation, the same pattern was even more pronounced, (68.2% vs. 13.3%, p<0.001 for !2 MVM's and 33.2% vs. 3.3%, p<0.001 for !3 MVM's).
In a multivariable regression model, maternal age and nulliparity were not found to influence this association. In a sub-analysis of only appropriately grown neonates (birthweight>10% percentile, n¼324), 35 0/7 gestational weeks remained a valid threshold (91.6% vs. 37.2% for !1 MVM's, 61.6% vs. 6.6% for !2 MVM's and 28.1% vs. 1.7% for !3 MVM's, p<0.001 for all) (Table) CONCLUSION: Based on the differences in the prevalence of MVM's in placental pathology specimens, the gestational age cut-off between early and late preeclampsia is 35 0/7 weeks. OBJECTIVE: Preeclampsia (PE) occurs in 3%e8% of all pregnancies and is a leading cause of maternal morbidity and mortality. Currently the only successful treatment for PE is delivery of the baby and placenta. Metformin, a biguanide medication, is used as treatment for type 2 diabetes and an acceptable oral agent for treatment of gestational diabetes. It has several mechanisms of action including targeting inflammatory, oxidative stress and vascular dysfunction pathways. Our hypothesis was that metformin reduces inflammation using an established obese mouse model of PE. STUDY DESIGN: Female CD-1 mice were fed high fat diet for 3 months, and then mated with CD-1 male. On day 1 of gestation, mice were randomly assigned to receive metformin (300 mg/kg, MET group) in drinking water or just plain drinking water (CTR group). On day 8 of gestation mice were injected with either adenovirus vector carrying sFl1 (AdsFlt1, 109 PFU/100 mL) or mFc (AdmFc, 109 PFU/100 mL as a virus control). Mice were sacrificed on day 18 of gestation and blood was collected. The levels of IL-6, Leptin, Insulin, Plasminogen activator inhibitor -1 (PAI-1), MCP-1, and Resistin were determined using LuminexÒ bead array. Data were analyzed using Student t-test or Mann-Whitney test as appropriate (significance was defined as p<0.05).
